Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GLP-1 Medication & Behavioral Health on Weight and Metabolic Outcomes: FLOURISH (Functional Longitudinal Outcomes Under Intentional Small Habits) & THRIVE (Trajectories of Health, Resilience & Integrated Vitality Evaluation) Cohort Study

NCT07588984 is registered in ClinicalTrials.gov with Noom Inc. as lead sponsor.

NCT NCT07588984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07588984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GLP-1 Medication & Behavioral Health on Weight and Metabolic Outcomes: FLOURISH (Functional Longitudinal Outcomes Under Intentional Small Habits) & THRIVE (Trajectories of Health, Resilience & Integrated Vitality Evaluation) Cohort Study
Lead sponsor
Noom Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2026
Completion date
May 31, 2029
Enrollment
2,310 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body weight, cardiovascular disease risk factor, obesity & overweight, preventative health, weight loss